跳至主要内容
临床试验/EUCTR2012-000866-40-IT
EUCTR2012-000866-40-IT进行中(未招募)不适用

Evaluation of the efficacy and suppression of the hypothalamic-pituitary-adrenal axis resulting in intrabursale single administration of cortisone in patients with calcific tendonitis of the rotator cuff '': randomized, controlled clinical trial - TPESP 2011-12

ISTITUTO ORTOPEDICO RIZZOLI0 个研究点开始时间: 2012年3月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients of both sexes, aged between 30-50 years, suffering from painful calcific tendonitis of the shoulder (calcification or mature phase of resorption) confirmed by ultrasound examination.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • enthesitis calcific shoulder
  • calcific tendinopathy with lesions of the rotator cuff
  • Septic arthritis or infection of the superficial tissues or periarticular
  • Disease hematologic or coagulation (liver failure ....)
  • metabolic diseases (diabetes)
  • Organ Transplant
  • collagenopatiche diseases or systemic inflammatory rheumatic (SLE, RA ..)
  • previous use of cortisone 2 months prior to TPE
  • Concomitant therapy with anticoagulants and / or antiplatelet
  • A history of asthma, allergic rhinitis, allergic conjunctivitis, bronchiectasis, sarcoidosis (erythema nodosum, uveitis ..), cystic fibrosis, COPD, Crohn's, ulcerative colitis
  • are allergic to cortisone derivatives
  • Pregnant or lactating

研究者

相似试验